- Home
- VERA vs NGD Comparison
VERA vs NGD Comparison
Compare VERA & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- NGD
- Stock Information
- Founded
- VERA 2016
- NGD N/A
- Country
- VERA United States
- NGD Canada
- Employees
- VERA N/A
- NGD N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- NGD
- Sector
- VERA Health Care
- NGD
- Exchange
- VERA Nasdaq
- NGD Nasdaq
- Market Cap
- VERA 2.4B
- NGD 2.4B
- IPO Year
- VERA 2021
- NGD 2004
- Fundamental
- Price
- VERA $28.58
- NGD $2.83
- Analyst Decision
- VERA Buy
- NGD Buy
- Analyst Count
- VERA 8
- NGD 4
- Target Price
- VERA $66.38
- NGD $3.23
- AVG Volume (30 Days)
- VERA 985.9K
- NGD 14.5M
- Earning Date
- VERA 03-19-2025
- NGD 02-19-2025
- Dividend Yield
- VERA N/A
- NGD N/A
- EPS Growth
- VERA N/A
- NGD N/A
- EPS
- VERA N/A
- NGD 0.02
- Revenue
- VERA N/A
- NGD $861,500,000.00
- Revenue This Year
- VERA N/A
- NGD $19.21
- Revenue Next Year
- VERA N/A
- NGD $28.63
- P/E Ratio
- VERA N/A
- NGD $119.51
- Revenue Growth
- VERA N/A
- NGD 14.85
- 52 Week Low
- VERA $25.99
- NGD $1.10
- 52 Week High
- VERA $51.61
- NGD $3.25
- Technical
- Relative Strength Index (RSI)
- VERA 29.57
- NGD 46.34
- Support Level
- VERA $25.99
- NGD $2.75
- Resistance Level
- VERA $34.79
- NGD $3.07
- Average True Range (ATR)
- VERA 2.15
- NGD 0.15
- MACD
- VERA -0.56
- NGD -0.03
- Stochastic Oscillator
- VERA 20.05
- NGD 18.75
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.